Eledon Pharmaceuticals Inc — Cash Flow (NASDAQ:ELDN) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 15.21 M28.9 M28.42 M39.53 M47.27 M 67.24 M Cash from investing activities 11.04 M11.04 M—45.29 M70.31 M 78.64 M Cash from financing activities 109.58 M449 K449 K33.02 M133.52 M 80.28 M Free cash flow 15.21 M28.9 M28.42 M39.53 M47.27 M 67.24 M

Новости

Tegoprubart от Eledon Pharmaceuticals: перспективный путь развития

Eledon Pharmaceuticals at Guggenheim Summit: Tegoprubart’s Promising Path

Eledon сообщает о положительных данных по трансплантации почки

Eledon reports positive 24-month kidney transplant data for tegoprubart

Tegoprubart от Eledon показывает перспективы в испытаниях при трансплантации почки

Eledon’s tegoprubart shows promise in kidney transplantation trials

Акции Eledon Pharmaceuticals растут после позитивных данных

Eledon Pharmaceuticals stock rises after positive islet transplant data

Антитело anti-CD40L от Eledon показывает перспективы в испытании диабета

Eledon’s anti-CD40L antibody shows promise in diabetes trial

Guggenheim lowers Eledon Pharmaceuticals stock price target on dilution

Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript